Article
17 Oct 2024
No Slowdown In Sight When It Comes To Focus On Drug Pricing Policy
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
15 Aug 2024
Happy Birthday Two You, IRA: Drug Pricing Dynamics To Watch As Maximum Fair Price Announcements Loom
Article
12 Aug 2024
The Health Over Wealth Act Takes Aim At Private Equity Investment In Health Care
Article
24 Jul 2024
The Corporate Crimes Against Health Care Act: Washington Continues Efforts To Chill Private Equity Investment In Health Care
Article
11 Jul 2024
Chevron Runs Out Of Gas: The Bumpy Road Ahead For Health Regulations After Loper Bright
Article
03 Jun 2024
High Stakes: HHS Shakes Things Up On Marijuana Scheduling And DEA Abides
Article
31 May 2024
Anti-Obesity Medications: Noteworthy Developments As Policymakers Weigh Coverage Considerations
Article
28 May 2024
2024 Guide To The IRA And Other Drug Pricing Initiatives: Impact On Life Sciences Investments
Article
09 May 2024
FDA Finalizes LDT Regulation, With Significant Exceptions: Enforcement Of Requirements Will Phase In Over Four Years
Article
01 May 2024
The Regulatory Race Is On: The Biden Administration Sprints To Issue Key Health Policies